vancomycin has been researched along with cefdinir in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Cha, JH; Chang, MH; Cho, YS; Choi, KI; Jeong, DY; Kim, D; Kim, Y; Kim, YH; Koh, HY; Kong, JY; Pae, AN; Park, SH; Park, SY | 1 |
Manno, M; Wing, R | 1 |
Kaul, M; LaVoie, EJ; Mark, L; Parhi, AK; Pilch, DS | 1 |
1 review(s) available for vancomycin and cefdinir
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for vancomycin and cefdinir
Article | Year |
---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Studies on novel 3-isoxazolylvinyl-cephalosporins: II. Synthesis and biological activity of 7-[2-(2-aminothiazol-4-yl)-2-hydroxy-iminoacetamido] derivatives.
Topics: Animals; Cefdinir; Cefpodoxime; Ceftizoxime; Cephalosporins; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin | 1998 |
Gone but not forgotten: a case of respiratory distress.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Cefdinir; Ceftriaxone; Cephalosporins; Child; Diagnosis, Differential; Dyspnea; Epiglottis; Epiglottitis; Humans; Intubation, Intratracheal; Male; Radiography; Vancomycin | 2015 |
Combining the FtsZ-Targeting Prodrug TXA709 and the Cephalosporin Cefdinir Confers Synergy and Reduces the Frequency of Resistance in Methicillin-Resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cefdinir; Cephalosporins; Cytoskeletal Proteins; Drug Synergism; Linezolid; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prodrugs; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2016 |